Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.

Fructose is a highly lipogenic sugar that can alter energy metabolism and trigger metabolic disorders. In the current study, microRNAs (miRNAs) altered by a high-fructose diet were comprehensively explored to elucidate their significance in the pathogenesis of chronic metabolic disorders. miRNA expression profiling using small noncoding RNA sequencing revealed that 19 miRNAs were significantly upregulated and 26 were downregulated in the livers of high-fructose-fed mice compared to chow-fed mice. Computational prediction and functional analysis identified 10 miRNAs, miR-19b-3p, miR-101a-3p, miR-30a-5p, miR-223-3p, miR-378a-3p, miR-33-5p, miR-145a-3p, miR-128-3p, miR-125b-5p and miR-582-3p, assembled as a regulatory network to potentially target key genes in lipid and lipoprotein metabolism and insulin signaling at multiple levels. qRT-PCR analysis of their potential target genes [IRS-1, FOXO1, SREBP-1c/2, ChREBP, insulin-induced gene-2 (Insig-2), microsomal triglyceride transfer protein (MTTP) and apolipoprotein B (apoB)] demonstrated that fructose-induced alterations of miRNAs were also reflected in mRNA expression profiles of their target genes. Moreover, the miRNA profile induced by high-fructose diet differed from that induced by high-fat diet, indicating that miRNAs mediate distinct pathogenic mechanisms in dietary-induced metabolic disorders. This study presents a comprehensive analysis of a new set of hepatic miRNAs, which were altered by high-fructose diet and provides novel insights into the interaction between miRNAs and their target genes in the development of metabolic syndrome.

[1]  J. Altomonte,et al.  PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1 , 2007 .

[2]  Tingming Liang,et al.  Deep Sequencing of Small RNA Repertoires in Mice Reveals Metabolic Disorders-Associated Hepatic miRNAs , 2013, PloS one.

[3]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[4]  Bhaskar Ponugoti,et al.  Role of Forkhead Transcription Factors in Diabetes-Induced Oxidative Stress , 2012, International Journal of Experimental Diabetes Research.

[5]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[6]  N. Kosaka,et al.  Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Takeshi Kimura,et al.  MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice , 2013, Nature Communications.

[8]  E. Pinatel,et al.  Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-γ , 2015, Cellular and molecular gastroenterology and hepatology.

[9]  Junjie Xiao,et al.  miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21 , 2015, Journal of cellular and molecular medicine.

[10]  Li Li,et al.  Role of microRNA-101a in the regulation of goat skeletal muscle satellite cell proliferation and differentiation. , 2015, Gene.

[11]  Wentong Li,et al.  Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer. , 2016, International journal of oncology.

[12]  C. Taniguchi,et al.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. , 2005, The Journal of clinical investigation.

[13]  H. Malhi,et al.  Mmu-miR-615-3p Regulates Lipoapoptosis by Inhibiting C/EBP Homologous Protein , 2014, PloS one.

[14]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[15]  R. Henry,et al.  Metabolic Consequence of Two-Week Fructose Feeding in Diabetic Subjects , 1986, Diabetes Care.

[16]  J. Goldstein,et al.  Liver-specific mRNA for Insig-2 down-regulated by insulin: Implications for fatty acid synthesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Zhifu Sun,et al.  CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data , 2014, BMC Genomics.

[18]  Arunmozhiarasi Armugam,et al.  MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus , 2011, PloS one.

[19]  R. Safaralizadeh,et al.  Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation , 2014, International journal of genomics.

[20]  Hsien-Da Huang,et al.  miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..

[21]  M. Bushell,et al.  The complexity of miRNA-mediated repression , 2014, Cell Death and Differentiation.

[22]  Manabu T. Nakamura,et al.  Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. , 2008, Biochimica et biophysica acta.

[23]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[24]  A. Tessitore,et al.  MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice , 2016, BMC Cancer.

[25]  Fen Hu,et al.  MicroRNA-101 protects cardiac fibroblasts from hypoxia-induced apoptosis via inhibition of the TGF-β signaling pathway. , 2015, The international journal of biochemistry & cell biology.

[26]  K. Moore,et al.  MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.

[27]  K. Adeli,et al.  Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. , 2010, American journal of physiology. Endocrinology and metabolism.

[28]  D. Accili,et al.  Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[29]  L. Kunkel,et al.  Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis , 2013, Journal of Cell Science.